Kyverna Therapeutics Inc (KYTX) PT Lowered to $33 at JPMorgan
Tweet
Share
E-mailGet Alerts KYTX Hot Sheet
Price: $8.17 +1.11%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Brian Cheng lowered the price target on Kyverna Therapeutics Inc (NASDAQ: KYTX) to $33.00 (from $39.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
